ALX-0171

· Ablynx (a Sanofi company)

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ALX-0171, covering 2018-07-13 to 2019-10-18. Get the full timeline:

Most recent: Clinical Trial Update: Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection [Phase 2]

See pricing